How will personalized medicine change business models?

Personalized medicine holds the potential to deliver many benefits for patients and other parties in the healthcare system, but it also has the potential to radically alter business models.

I have asked the question “Will personalized medicine be a driver for widespread price controls?” and a new analysis from Booz & Company dives even deeper and A Strategist’s Guide to Personalized Medicine.

What are your thoughts on the extra-patient/payer benefits that personalized medicine will bring, and how the biopharma industry should adjust? Sound off in the comments below.

   No Comments yet

  1. Mike Smith
      November 12, 2012

    This is a good article. I gained a lot of insights. Have the authors published anything about specific models in personalized medicine that takes this thinking one step deeper? For example, what are the specific capabilities that will be required to make sure that healthcare constituents can integrate personalized medicine into healthcare delivery? Can these capabilities be partnered or will a company have to build them?

Do NOT follow this link or you will be banned from the site!